Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Colorectal Neoplasms

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 42 articles:
HTML format



Single Articles


    August 2023
  1. SACHER A, LoRusso P, Patel MR, Miller WH Jr, et al
    Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation.
    N Engl J Med. 2023;389:710-721.
    PubMed     Abstract available


    July 2023
  2. DOSSA F, Baxter NN
    Changing the Treatment Paradigm for Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:375-377.
    PubMed    


  3. SCHRAG D, Shi Q, Weiser MR, Gollub MJ, et al
    Preoperative Treatment of Locally Advanced Rectal Cancer.
    N Engl J Med. 2023;389:322-334.
    PubMed     Abstract available


  4. TABERNERO J, Fakih M, Prager GW
    Third-Line Therapy in Metastatic Colorectal Cancer. Reply.
    N Engl J Med. 2023;389:190-191.
    PubMed    


  5. VAN DE HAAR J, Valeri N, Voest EE
    Third-Line Therapy in Metastatic Colorectal Cancer.
    N Engl J Med. 2023;389:190.
    PubMed    


    May 2023
  6. YEKU OO, Longo DL
    Combination Therapy, Including Bevacizumab, for Advanced Colorectal Cancer.
    N Engl J Med. 2023;388:1711-1714.
    PubMed    


  7. PRAGER GW, Taieb J, Fakih M, Ciardiello F, et al
    Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
    N Engl J Med. 2023;388:1657-1667.
    PubMed     Abstract available


    March 2023
  8. CALLISON K, Pesko MF, Phillips S, Sosa JA, et al
    Cancer Screening after the Adoption of Paid-Sick-Leave Mandates.
    N Engl J Med. 2023;388:824-832.
    PubMed     Abstract available


    January 2023
  9. DOMINITZ JA, Robertson DJ
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
    N Engl J Med. 2023;388:379.
    PubMed    


  10. BRETTHAUER M, Loberg M, Kaminski MF
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality. Reply.
    N Engl J Med. 2023;388:378-379.
    PubMed    


  11. CAPPELL MS, Tobi M, Yang YX
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:378.
    PubMed    


  12. HOFFMEISTER M, Cardoso R, Brenner H
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377-378.
    PubMed    


  13. WINAWER SJ
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:377.
    PubMed    


  14. DECK W
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376-377.
    PubMed    


  15. HANLEY JA
    Colonoscopy Screening and Colorectal Cancer Incidence and Mortality.
    N Engl J Med. 2023;388:376.
    PubMed    


    December 2022
  16. YAEGER R, Weiss J, Pelster MS, Spira AI, et al
    Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
    N Engl J Med. 2022 Dec 21. doi: 10.1056/NEJMoa2212419.
    PubMed     Abstract available


    November 2022
  17. PAPKE DJ JR, Yurgelun MB, Noffsinger AE, Turner KO, et al
    Prevalence of Mismatch-Repair Deficiency in Rectal Adenocarcinomas.
    N Engl J Med. 2022;387:1714-1716.
    PubMed    


    October 2022
  18. DOMINITZ JA, Robertson DJ
    Understanding the Results of a Randomized Trial of Screening Colonoscopy.
    N Engl J Med. 2022;387:1609-1611.
    PubMed    


  19. BRETTHAUER M, Loberg M, Wieszczy P, Kalager M, et al
    Effect of Colonoscopy Screening on Risks of Colorectal Cancer and Related Death.
    N Engl J Med. 2022 Oct 9. doi: 10.1056/NEJMoa2208375.
    PubMed     Abstract available


    September 2022
  20. CERCEK A, Diaz LA Jr
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer. Reply.
    N Engl J Med. 2022;387:855-856.
    PubMed    


  21. GANGULY S, Gogia A
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:855.
    PubMed    


  22. COPUR MS, Tun SM, Duckert R
    PD-1 Blockade in Mismatch Repair-Deficient Rectal Cancer.
    N Engl J Med. 2022;387:854-855.
    PubMed    


    August 2022
  23. TIE J, Lo SN, Gibbs P
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer. Reply.
    N Engl J Med. 2022;387:760.
    PubMed    


  24. OTSUKA M
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759-760.
    PubMed    


  25. HINDIE E
    Circulating Tumor DNA Guiding Adjuvant Therapy in Colon Cancer.
    N Engl J Med. 2022;387:759.
    PubMed    


  26. PALEFSKY JM, Lee JY
    Prevention of Anal Cancer. Reply.
    N Engl J Med. 2022;387:666-667.
    PubMed    


  27. REVOLLO B, Videla S, Llibre JM
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:666.
    PubMed    


  28. KREUTER A, Wieland U
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665-666.
    PubMed    


  29. GOFFREDO P, Klemen ND, Hassan I
    Prevention of Anal Cancer.
    N Engl J Med. 2022;387:665.
    PubMed    


    July 2022
  30. SINICROPE FA
    The Increasing Incidence of Early-Onset Colorectal Cancer. Reply.
    N Engl J Med. 2022;387:93-94.
    PubMed    


  31. GOLDSTEIN MR, Mascitelli L
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:93.
    PubMed    


  32. WOLOSHIN S, Kramer BS
    The Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;387:91-93.
    PubMed    


    June 2022
  33. SANOFF HK
    Improving Treatment Approaches for Rectal Cancer.
    N Engl J Med. 2022;386:2425-2426.
    PubMed    


  34. CERCEK A, Lumish M, Sinopoli J, Weiss J, et al
    PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.
    N Engl J Med. 2022;386:2363-2376.
    PubMed     Abstract available


  35. PALEFSKY JM, Lee JY, Jay N, Goldstone SE, et al
    Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.
    N Engl J Med. 2022;386:2273-2282.
    PubMed     Abstract available


  36. BASGOZ N, Brown CM, Smole SC, Madoff LC, et al
    Case 24-2022: A 31-Year-Old Man with Perianal and Penile Ulcers, Rectal Pain, and Rash.
    N Engl J Med. 2022 Jun 15. doi: 10.1056/NEJMcpc2201244.
    PubMed    


  37. TIE J, Cohen JD, Lahouel K, Lo SN, et al
    Circulating Tumor DNA Analysis Guiding Adjuvant Therapy in Stage II Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMoa2200075.
    PubMed     Abstract available


  38. MONTAGUT C, Vidal J
    Liquid Biopsy for Precision Adjuvant Chemotherapy in Colon Cancer.
    N Engl J Med. 2022 Jun 4. doi: 10.1056/NEJMe2204625.
    PubMed    


    April 2022
  39. SINICROPE FA
    Increasing Incidence of Early-Onset Colorectal Cancer.
    N Engl J Med. 2022;386:1547-1558.
    PubMed    


    February 2022
  40. DOUBENI CA, Corley DA, Zhao W, Lau Y, et al
    Association between Improved Colorectal Screening and Racial Disparities.
    N Engl J Med. 2022;386:796-798.
    PubMed    


  41. MIN A, Ditkofsky N
    Page Kidneys.
    N Engl J Med. 2022;386:673.
    PubMed    


    January 2022
  42. HORN DM, Haas JS
    Expanded Lung and Colorectal Cancer Screening - Ensuring Equity and Safety under New Guidelines.
    N Engl J Med. 2022 Jan 8. doi: 10.1056/NEJMp2113332.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: